000650 Renhe Pharmacy
- 6.59
- +0.04+0.61%
Renhe Pharmacy News
Renhe Pharmacy: Announcement on the Company's subsidiary obtaining a drug registration certificate
Renhe Pharmacy: 000650 Renhe Pharmaceutical Investor Relations Management Information 20240522
Renhe Pharmacy: Legal Opinion on Renhe Pharmaceutical's Phase II Employee Stock Ownership Plan
Renhe Pharmacy: Announcement on participating in the 2024 Investor Online Group Reception Day
Renhe Pharmacy: 000650 Renhe Pharmaceutical Investor Relations Management Information 20240510
Renhe Pharmacy: Announcement of Resolutions of the 14th Meeting of the 9th Board of Supervisors of the Company
Renhe Pharmacy: Audit opinion of the board of supervisors on the company's second employee stock ownership plan
Renhe Pharmacy: Announcement of Resolutions of the 20th Interim Meeting of the 9th Board of Directors of the Company
Renhe Pharmacy: Audit opinion of the board of supervisors on the company's second employee stock ownership plan
Renhe Pharmaceutical: Special opinion of the board of directors on the evaluation of the independence of independent directors
Renhe Pharmaceutical: 2023 Independent Director Debriefing Report (Guo Yaxiong)
Renhe Pharmaceutical: 2023 Annual Audit Report
Renhe Pharmaceutical: Company Announcement on Holding the 2023 Online Results Briefing
Renhe Pharmaceutical: Announcement of Board of Supervisory Committee Resolutions
Renhe Pharmaceutical: Report of the Board of Directors on the Evaluation of the Performance of Accounting Firms in 2023
Renhe Pharmaceutical: 2023 Work Report of the Company's Supervisory Committee
Renhe Pharmaceutical: Company Announcement on Changing the Accounting Firm and Hiring an Auditor for 2024
Renhe Pharmaceutical: Independent Director's Annual Debriefing Report
Renhe Pharmaceutical: Announcement on the company's daily related transaction forecast for 2024
Renhe Pharmaceutical: Announcement of Board Resolutions
Analysis
Price Target
No Data
